Routine Gene Testing For Plavix Patients Unsupported By Evidence - ACC/AHA
This article was originally published in The Gray Sheet
Executive Summary
The evidence base is insufficient to support routine genetic or platelet function testing to assess a patient's responsiveness to the anti-clotting drug clopidogrel, according to new cardiovascular society guidelines